Published in Cardiovascular Week, February 1st, 2010
"We are pleased to announce the FDA clearance of REEF HP, a strong and highly stable balloon, designed specifically to treat the most demanding lesions with a high pressure threshold," commented Stefan Widensohler and Andrea Venturelli, co-founders of Invatec. "The 'lesion-specific' design of REEF...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Week
Source: Cardiovascular Week (2010-02-01)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.